Hot Pursuit     26-Feb-24
Zydus Lifesciences Ltd spurts 1.16%, rises for third straight session
Zydus Lifesciences Ltd is quoting at Rs 934, up 1.16% on the day as on 12:49 IST on the NSE. The stock is up 104.8% in last one year as compared to a 27.04% gain in NIFTY and a 58.2% gain in the Nifty Pharma index.

Zydus Lifesciences Ltd rose for a third straight session today. The stock is quoting at Rs 934, up 1.16% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.52% on the day, quoting at 22096.3. The Sensex is at 72763.45, down 0.52%. Zydus Lifesciences Ltd has added around 24.78% in last one month.

Meanwhile, Nifty Pharma index of which Zydus Lifesciences Ltd is a constituent, has added around 6.84% in last one month and is currently quoting at 19048.4, down 1.15% on the day. The volume in the stock stood at 8.95 lakh shares today, compared to the daily average of 14.56 lakh shares in last one month.

The benchmark February futures contract for the stock is quoting at Rs 934.8, up 1.14% on the day. Zydus Lifesciences Ltd is up 104.8% in last one year as compared to a 27.04% gain in NIFTY and a 58.2% gain in the Nifty Pharma index.

The PE of the stock is 34.73 based on TTM earnings ending December 23.

Previous News
  Zydus and Dr Reddy's ink licensing agreement to co-market Pertuzumab in India
 ( Corporate News - 28-Jun-24   19:04 )
  Zydus Lifesciences Ltd drops for fifth straight session
 ( Hot Pursuit - 19-Sep-24   13:35 )
  Zydus completes acquisition of 50% stake in Sterling Biotech
 ( Corporate News - 30-Aug-24   11:21 )
  Zydus Lifesciences receives USFDA approval for Scopolamine Transdermal System
 ( Corporate News - 30-Aug-24   15:12 )
  Zydus Life gets USFDA nod for Methylene Blue injection
 ( Hot Pursuit - 06-Dec-23   14:50 )
  Zydus' transdermal manufacturing site completes USFDA inspection
 ( Corporate News - 19-Jul-24   19:26 )
  Zydus Life Jarod facility receives USFDA warning letter
 ( Hot Pursuit - 30-Aug-24   15:11 )
  Zydus receives WHO approval for the name ‘Usnoflast' for ZYIL1
 ( Corporate News - 01-Apr-24   20:34 )
  Zydus Life gets US FDA nod for seizure treatment drug Lacosamide
 ( Hot Pursuit - 16-Dec-23   15:37 )
  Zydus Life Ahmedabad facility clears USFDA inspection
 ( Hot Pursuit - 08-Jul-23   11:47 )
  Board of Zydus Lifesciences to consider buyback of shares
 ( Corporate News - 05-Feb-24   18:54 )
Other Stories
  UCO Bank’s total advances jump 19% YoY in Q2 FY25
  04-Oct-24   15:15
  Vakrangee Ltd leads losers in 'A' group
  04-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  04-Oct-24   14:45
  GRSE bags Rs 226-cr LoA from West Bengal Govt
  04-Oct-24   14:40
  Volumes soar at Avenue Supermarts Ltd counter
  04-Oct-24   14:30
  Real Estate stocks edge lower
  04-Oct-24   14:00
  Auto stocks edge lower
  04-Oct-24   14:00
  Utilties stocks edge lower
  04-Oct-24   14:00
  HDFC Bank Ltd down for fifth straight session
  04-Oct-24   13:35
  Power Grid Corporation of India Ltd down for fifth straight session
  04-Oct-24   13:35
Back Top